Alclofenac
CAS No. 22131-79-9
Alclofenac( W 7320 | W-7320 | W7320 | MY 101 | BRN 2116510 )
Catalog No. M27947 CAS No. 22131-79-9
Alclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 25MG | 94 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlclofenac
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
-
DescriptionAlclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
-
In Vitro——
-
In Vivo——
-
SynonymsW 7320 | W-7320 | W7320 | MY 101 | BRN 2116510
-
PathwayOthers
-
TargetOther Targets
-
Recptorvitamin D receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22131-79-9
-
Formula Weight226.66
-
Molecular FormulaC11H11ClO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)Cc1ccc(OCC=C)c(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Al-Jaderi Z, et al. Effects of vitamin D3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells. Toxins (Basel). 2013 Oct 28;5(11):1932-47.
molnova catalog
related products
-
Cyclamic acid
Cyclamic acid in the form of its sodium or calcium salt is one of the most widely used artificial sweeteners.
-
GSK-626616
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
-
Citronellal
Citronellal is a monoterpene predominantly formed by the secondary metabolism of plants producing antithrombotic antiplatelet and antihypertensive activities.
Cart
sales@molnova.com